A61K 9/145
With organic compounds
Official title: {with organic compounds}
A61K9/145 (With organic compounds) appears on 1,357 US grants and 2,508 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,357
- Published applications
- 2,508
- Assignees
- 1,123
- Inventors
- 4,376
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 6 | 0 |
| 1992 | 3 | 0 |
| 1993 | 7 | 0 |
| 1994 | 5 | 0 |
| 1995 | 4 | 0 |
| 1996 | 10 | 0 |
| 1997 | 10 | 0 |
| 1998 | 7 | 0 |
| 1999 | 23 | 0 |
| 2000 | 19 | 0 |
| 2001 | 35 | 13 |
| 2002 | 25 | 53 |
| 2003 | 39 | 88 |
| 2004 | 20 | 86 |
| 2005 | 20 | 72 |
| 2006 | 20 | 83 |
| 2007 | 22 | 77 |
| 2008 | 11 | 69 |
| 2009 | 13 | 51 |
| 2010 | 30 | 79 |
| 2011 | 30 | 68 |
| 2012 | 36 | 88 |
| 2013 | 46 | 83 |
| 2014 | 59 | 136 |
| 2015 | 86 | 138 |
| 2016 | 77 | 145 |
| 2017 | 94 | 137 |
| 2018 | 75 | 127 |
| 2019 | 77 | 129 |
| 2020 | 58 | 127 |
| 2021 | 61 | 121 |
| 2022 | 76 | 120 |
| 2023 | 77 | 127 |
| 2024 | 48 | 117 |
| 2025 | 75 | 115 |
| 2026 | 37 | 59 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Implants for release of lipophilic or amphiphilic pharmaceutical substances29 Sep 2026US 12,746,275 B2ReacX Pharmaceuticals, Inc.
- Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto15 Sep 2026US 12,734,145 B2Children's Healthcare of Atlanta, Inc.
- Stable lyophilized composition of pemetrexed dipotassium1 Sep 2026US 12,721,811 B1AVYXA Pharma
- Nanometric pharmaceutical composition in the form of liposomes or nanoemulsion containing specific sequences of interference RNA18 Aug 2026US 12,708,671 B2
- Solid composition4 Aug 2026US 12,697,303 B2University of Lancashire
- Compositions, devices, and methods for intranasal delivery of dry powder epinephrine1 Oct 2026US 2026/0295182 A1Belhaven BioPharma Inc.
- Glycopyrrolate salts24 Sep 2026US 2026/0284007 A1Journey Medical Corporation
- Compositions, devices, and methods for intranasal delivery of dry powder epinephrine24 Sep 2026US 2026/0284335 A1Belhaven BioPharma Inc.
- Sublingual formulation with water-soluble cocrystals of acetylsalicylic acid with citric acid, sodium bicarbonate, and l-theanine for the treatment of acute myocardial infarction17 Sep 2026US 2026/0272826 A1Theaprin Pharmaceuticals Inc.
- Formation of co-crystals17 Sep 2026US 2026/0272840 A1Indicatrix Crystallography Ltd.
Most cited
By later US patents
- Surface modified drug nanoparticles993US 5,145,684 ASterling Drug Inc. · 1992
- Surface modified anticancer nanoparticles469US 5,399,363 AEastman Kodak Company · 1995
- Lipsopheres for controlled delivery of substances424US 5,188,837 ANova Pharmaceutical Corporation · 1993
- Extruded orally administrable opioid formulations380US 5,958,452 AEuro-Celtique S. A. · 1999
- Extruded multi-particulates364US 5,965,161 AEuro-Celtique S. A. · 1999